We review here findings for the CCL2-CCR2 and CCL3-CCR5 chemokine-receptor systems that show the effects of these molecules on T cell differentiation. Possible roles of other chemokines and G ...
Cenicriviroc is a first-in-class inhibitor of the CCR5 and CCR2 receptors that recently completed Phase II evaluation. This drug is promising because of the possibility that CCR2 inhibition may ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback